Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers B > Headlines for BioSante Pharmaceuticals Inc. > News item |
BioSante Pharmaceuticals files $75 million shelf for stock, preferreds
By Devika Patel
Knoxville, Tenn., May 21 - BioSante Pharmaceuticals Inc. filed a $75 million shelf registration in an S-3 filing with the Securities and Exchange Commission.
The registration covers common stock, preferred stock, units and warrants.
The preferreds may be structured as convertibles.
Proceeds will be used for general corporate purposes.
Based in Lincolnshire, Ill., BioSante is a biotechnology company focused on hormone therapies.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.